Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:47 pm Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | ARMISTICE CAPITAL LLC | 8,200,000 5.730% | -1,336,000 (-14.01%) | View |
| 2024-09-12 4:10 pm Purchase | 13D | Aurinia Pharmaceuticals Inc. AUPH | TANG CAPITAL MANAGEMENT LLC | 7,229,500 5.100% | 7,229,500 (New Position) | View |
| 2024-03-20 5:23 pm Purchase | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,539,891 13.000% | 355,993 (+4.96%) | View |
| 2024-02-14 3:27 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | ARMISTICE CAPITAL LLC | 9,536,000 6.640% | 9,536,000 (New Position) | View |
| 2024-02-12 09:41 am Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | BlackRock Inc. BLK | 8,921,049 6.200% | 750,531 (+9.19%) | View |
| 2023-05-10 4:30 pm Unchanged | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | 0 (Unchanged) | View |
| 2023-02-14 08:29 am Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | Deep Track Capital LP | 324,238 0.230% | -7,517,332 (-95.87%) | View |
| 2023-02-07 12:59 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | BlackRock Inc. BLK | 8,170,518 5.700% | 8,170,518 (New Position) | View |
| 2023-01-20 4:30 pm Unchanged | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | 0 (Unchanged) | View |
| 2023-01-06 4:30 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 7,183,898 13.000% | -1,093,902 (-13.21%) | View |
| 2022-10-28 4:10 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | Deep Track Capital LP | 7,841,570 5.530% | 7,841,570 (New Position) | View |
| 2022-03-03 4:15 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 8,277,800 13.000% | -717,639 (-7.98%) | View |
| 2022-02-14 10:30 am Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | HealthCor Management L.P. | 0 0.000% | -6,937,448 (Position Closed) | View |
| 2021-03-10 9:41 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | Growth Equity Opportunities Fund III LLC | 0 0.000% | -5,593,342 (Position Closed) | View |
| 2021-02-17 2:22 pm Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-16 2:19 pm Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 6,058,505 11.000% | -567,166 (-8.56%) | View |
| 2021-02-12 4:09 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | HealthCor Management L.P. | 6,937,448 5.500% | 1,116,808 (+19.19%) | View |
| 2021-02-08 10:15 am Sale | 13G | Aurinia Pharmaceuticals Inc. AUPH | FMR LLC | 5,762,773 4.557% | -2,267,285 (-28.23%) | View |
| 2021-01-27 4:14 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 8,995,439 7.100% | -1,536,675 (-14.59%) | View |
| 2021-01-26 4:06 pm Sale | 13D | Aurinia Pharmaceuticals Inc. AUPH | ILJIN SNT Co. Ltd. | 10,532,114 8.300% | -1,237,922 (-10.52%) | View |